Prognosis of Patients With AJCCv8 Stage I and II Primary Melanoma Validated in Two Independent Cohorts
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment
J. Clin. Oncol 2022 Jun 16;[EPub Ahead of Print], C Garbe, U Keim, T Amaral, C Berking, TK Eigentler, L Flatz, A Gesierich, U Leiter, R Stadler, C Sunderkötter, T Tüting, J Utikal, U Wollina, L Zimmer, CC Zouboulis, PA Ascierto, AMM Eggermont, JJ Grob, A Hauschild, LK Sekulovic, GV Long, JJ Luke, O Michielin, K Peris, D Schadendorf, JM Kirkwood, PC LoriganFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.